INS and prostate carcinoma: We anticipated detection of an interaction between c-peptide, a biomarker for insulin, and 25(OH)D with prostate cancer, as we have found high levels of c-peptide to be associated with a near two-fold increased risk for high-grade prostate cancer [48].